Search research articles
Contact Us
Filters
Showing results (101-110 of 123) with videos related to
Page
of 13
Sort By:
Journal of Clinical Psychopharmacology
|
August 5, 2000
Intravenous versus oral administration of amitriptyline in patients with major depression
E A Deisenhammer, A B Whitworth, C Geretsegger, et al.
Lancet (London, England)
|
May 25, 1996
Comparison of acamprosate and placebo in long-term treatment of alcohol dependence
A B Whitworth, F Fischer, O M Lesch, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
December 1, 1993
The effect of activation procedures on neuroleptic-induced akathisia
W W Fleischhacker, C H Miller, C Barnas, et al.
Addiction (Abingdon, England)
|
October 1, 1994
Assessment of the alcohol withdrawal syndrome--validity and reliability of the translated and modified Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-A)
C H Stuppaeck, C Barnas, M Falk, et al.
Molecular Psychiatry
|
September 1, 2005
Olanzapine impairs glycogen synthesis and insulin signaling in L6 skeletal muscle cells
J Engl, M Laimer, A Niederwanger, et al.
Acta Psychiatrica Scandinavica
|
November 16, 2017
Religiosity and psychological resilience in patients with schizophrenia and bipolar disorder: an international cross-sectional study
Y Mizuno, A Hofer, B Frajo-Apor, et al.
Acta Psychiatrica Scandinavica
|
August 7, 2016
Quality of life in stabilized patients with schizophrenia is mainly associated with resilience and self-esteem
F Wartelsteiner, Y Mizuno, B Frajo-Apor, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 27, 2001
Quality of life measurement in oncology--a matter of the assessment instrument?
B Holzner, G Kemmler, B Sperner-Unterweger, et al.
British Journal of Addiction
|
February 1, 1991
Change in HIV-antibody seroprevalence rates in i.v. drug dependent prisoners
B Sperner-Unterweger, D Fuchs, W W Fleischhacker, et al.
Neuropsychobiology
|
January 1, 1992
A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder
W W Fleischhacker, H Hinterhuber, H Bauer, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 123) with videos related to
Sort By:
Page
of 13
Journal of Clinical Psychopharmacology
|
August 5, 2000
Intravenous versus oral administration of amitriptyline in patients with major depression
E A Deisenhammer, A B Whitworth, C Geretsegger, et al.
Lancet (London, England)
|
May 25, 1996
Comparison of acamprosate and placebo in long-term treatment of alcohol dependence
A B Whitworth, F Fischer, O M Lesch, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
December 1, 1993
The effect of activation procedures on neuroleptic-induced akathisia
W W Fleischhacker, C H Miller, C Barnas, et al.
Addiction (Abingdon, England)
|
October 1, 1994
Assessment of the alcohol withdrawal syndrome--validity and reliability of the translated and modified Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-A)
C H Stuppaeck, C Barnas, M Falk, et al.
Molecular Psychiatry
|
September 1, 2005
Olanzapine impairs glycogen synthesis and insulin signaling in L6 skeletal muscle cells
J Engl, M Laimer, A Niederwanger, et al.
Acta Psychiatrica Scandinavica
|
November 16, 2017
Religiosity and psychological resilience in patients with schizophrenia and bipolar disorder: an international cross-sectional study
Y Mizuno, A Hofer, B Frajo-Apor, et al.
Acta Psychiatrica Scandinavica
|
August 7, 2016
Quality of life in stabilized patients with schizophrenia is mainly associated with resilience and self-esteem
F Wartelsteiner, Y Mizuno, B Frajo-Apor, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 27, 2001
Quality of life measurement in oncology--a matter of the assessment instrument?
B Holzner, G Kemmler, B Sperner-Unterweger, et al.
British Journal of Addiction
|
February 1, 1991
Change in HIV-antibody seroprevalence rates in i.v. drug dependent prisoners
B Sperner-Unterweger, D Fuchs, W W Fleischhacker, et al.
Neuropsychobiology
|
January 1, 1992
A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder
W W Fleischhacker, H Hinterhuber, H Bauer, et al.
Page
of 13